Journal article · 2026 · Open access

Pharmaceutical Industry Pay‐Per‐Click Advertising Strategies to Influence Public Opinions on Drug Pricing

Daniel Eisenkraft Klein, Aaron Seth Kesselheim

Clinical Pharmacology & Therapeutics · Published 2 November 2026 · DOI 10.1002/cpt.70538

Open PDFView at the publisherCite this paper

In brief

“Pharmaceutical Industry Pay‐Per‐Click Advertising Strategies to Influence Public Opinions on Drug Pricing” is a 2026 journal article by Daniel Eisenkraft Klein and Aaron Seth Kesselheim, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 0 citations as of 17 November 2026. It is open access: the full text is free to read at Clinical Pharmacology & Therapeutics.

Citations
0
References
6
Authors
2

Abstract

This analysis characterizes the magnitude, timing, and keyword targeting strategies of the Pharmaceutical Research and Manufacturers of America's (PhRMA) pay-per-click advertising expenditures and their relation to major drug pricing policy developments (2019-2025). Pay-per-click advertising allows advertisers to purchase prominent placement in search engine results, allowing their content to appear above organic results when users search for specific terms. We extracted pay-per-click advertising data from Semrush, a commercial digital marketing intelligence platform, for the domain www.phrma.org from February 2019 through December 2025. We classified keywords into mutually exclusive categories using a specificity-based pattern-matching algorithm and categorized landing-page URLs by content theme using URL string matching. We analyzed monthly spending against a timeline of major legislative and regulatory events. PhRMA spent an estimated $58.8 million across 283,517 keyword instances, generating 17.1 million paid visits to phrma.org and its subdomains. Insurance and health plan keywords dominated spending ($32.4 million; 55.1%), including general and non-health insurance terms. Nearly half of total expenditures (47.5%; $27.9 million) drove traffic to pages classified as criticizing pharmacy benefit managers. Monthly spending showed little linear association with the selected Google Trends index (r = -0.05), but spending surged around well-publicized US legislative and regulatory actions, peaking at $4.8 million in May 2023; March-September 2023 accounted for 36.5% of total spending. Overall, PhRMA pay-per-click spending surges coincided with major US drug pricing policy developments.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Klein, D. E., & Kesselheim, A. S. (2026). Pharmaceutical Industry Pay‐Per‐Click Advertising Strategies to Influence Public Opinions on Drug Pricing. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70538

MLA 9

Klein, Daniel Eisenkraft, and Aaron Seth Kesselheim. “Pharmaceutical Industry Pay‐Per‐Click Advertising Strategies to Influence Public Opinions on Drug Pricing.” Clinical Pharmacology & Therapeutics, 2026. https://doi.org/10.1002/cpt.70538.

Chicago

Klein, Daniel Eisenkraft and Aaron Seth Kesselheim. 2026. “Pharmaceutical Industry Pay‐Per‐Click Advertising Strategies to Influence Public Opinions on Drug Pricing.” Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70538.

Harvard

Klein, D. E. and Kesselheim, A. S. (2026) ‘Pharmaceutical Industry Pay‐Per‐Click Advertising Strategies to Influence Public Opinions on Drug Pricing’, Clinical Pharmacology & Therapeutics. doi:10.1002/cpt.70538.

IEEE

D. E. Klein and A. S. Kesselheim, “Pharmaceutical Industry Pay‐Per‐Click Advertising Strategies to Influence Public Opinions on Drug Pricing,” Clinical Pharmacology & Therapeutics, 2026, doi: 10.1002/cpt.70538.

BibTeX

@article{klein2026pharmaceutical,
  title     = {{Pharmaceutical Industry Pay‐Per‐Click Advertising Strategies to Influence Public Opinions on Drug Pricing}},
  author    = {Klein, Daniel Eisenkraft and Kesselheim, Aaron Seth},
  journal   = {Clinical Pharmacology \& Therapeutics},
  year      = {2026},
  doi       = {10.1002/cpt.70538},
  url       = {https://doi.org/10.1002/cpt.70538}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare

  • pay-per-click advertising
  • pharmaceutical industry
  • drug pricing policy
  • keyword targeting
  • search engine advertising
  • pharmaceutical lobbying
  • pharmacy benefit managers

Work with this paper

Most-cited papers in Nursing

All highly cited Nursing papers

Questions about this paper

How do I cite this paper in APA style?

Klein, D. E., & Kesselheim, A. S. (2026). Pharmaceutical Industry Pay‐Per‐Click Advertising Strategies to Influence Public Opinions on Drug Pricing. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70538

How many times has this paper been cited?

0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.

Who wrote this paper?

Daniel Eisenkraft Klein, Aaron Seth Kesselheim.

What is the DOI of this paper?

10.1002/cpt.70538, permanently at https://doi.org/10.1002/cpt.70538. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.